Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
Sales | 184 | 0 | 0 | 7,015 | 7,908 |
Gross Profit | 184 | N/A | N/A | 7,015 | 7,908 |
Operating Expenses | 63,211 | 45,101 | 17,378 | 16,265 | 15,521 |
Operating Income | -63,027 | -45,101 | -17,378 | -9,250 | -7,613 |
Interest Expense | 0 | 199 | 952 | 1,342 | 997 |
Other Income | 188 | -2,639 | -188 | 471 | 54 |
Pre-tax Income | -62,839 | -47,939 | -18,518 | -10,121 | -8,556 |
Net Income Continuous | -62,839 | -47,939 | -18,518 | -10,121 | -8,556 |
Net Income | $-62,839 | $-47,939 | $-18,518 | $-10,121 | $-8,556 |
EPS Basic Total Ops | -3.09 | -3.00 | -709.57 | -516.00 | -492.76 |
EPS Basic Continuous Ops | -3.09 | -2.98 | -628.52 | -367.32 | -333.15 |
EPS Diluted Total Ops | -3.09 | -3.00 | -709.57 | -516.00 | -492.76 |
EPS Diluted Continuous Ops | -3.09 | -2.98 | -628.52 | -367.32 | -333.15 |
EPS Diluted Before Non-Recurring Items | -3.09 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-62,166 | $-44,253 | $-16,638 | $-8,474 | $-6,785 |